List of Excipients in API hydrocortisone valerate
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing hydrocortisone valerate
Detailed excipient profiles for hydrocortisone valerate
Excipient focus: ACRYLAMIDE
hydrocortisone valerate drug variants containing ACRYLAMIDE
| Company | Ingredient | NDC |
|---|---|---|
| Glenamrk Pharmaceuticals Inc USA | hydrocortisone valerate | 68462-575 |
| Glenmark Pharmaceuticals Inc USA | hydrocortisone valerate | 68462-836 |
| >Company | >Ingredient | >NDC |
hydrocortisone valerate drug variants not containing ACRYLAMIDE
Excipient focus: CARBOMER HOMOPOLYMER TYPE B
hydrocortisone valerate drug variants containing CARBOMER HOMOPOLYMER TYPE B
| Company | Ingredient | NDC |
|---|---|---|
| Cosette Pharmaceuticals Inc | hydrocortisone valerate | 0713-0560 |
| Cosette Pharmaceuticals Inc | hydrocortisone valerate | 0713-0669 |
| >Company | >Ingredient | >NDC |
hydrocortisone valerate drug variants not containing CARBOMER HOMOPOLYMER TYPE B
Excipient focus: CARBOMER HOMOPOLYMER TYPE C
hydrocortisone valerate drug variants containing CARBOMER HOMOPOLYMER TYPE C
hydrocortisone valerate drug variants not containing CARBOMER HOMOPOLYMER TYPE C
Excipient focus: CITRIC ACID MONOHYDRATE
hydrocortisone valerate drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Glenamrk Pharmaceuticals Inc USA | hydrocortisone valerate | 68462-575 |
| >Company | >Ingredient | >NDC |
hydrocortisone valerate drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: ISOHEXADECANE
hydrocortisone valerate drug variants containing ISOHEXADECANE
| Company | Ingredient | NDC |
|---|---|---|
| Glenamrk Pharmaceuticals Inc USA | hydrocortisone valerate | 68462-575 |
| Glenmark Pharmaceuticals Inc USA | hydrocortisone valerate | 68462-836 |
| >Company | >Ingredient | >NDC |
hydrocortisone valerate drug variants not containing ISOHEXADECANE
Excipient focus: LIGHT MINERAL OIL
hydrocortisone valerate drug variants containing LIGHT MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| Cosette Pharmaceuticals Inc | hydrocortisone valerate | 0713-0560 |
| >Company | >Ingredient | >NDC |
hydrocortisone valerate drug variants not containing LIGHT MINERAL OIL
Excipient focus: METHYLPARABEN
hydrocortisone valerate drug variants containing METHYLPARABEN
hydrocortisone valerate drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | hydrocortisone valerate | 45802-455 |
| A-S Medication Solutions | hydrocortisone valerate | 50090-2525 |
| DIRECT RX | hydrocortisone valerate | 61919-010 |
| >Company | >Ingredient | >NDC |
Excipient focus: MINERAL OIL
hydrocortisone valerate drug variants containing MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| Cosette Pharmaceuticals Inc | hydrocortisone valerate | 0713-0669 |
| Glenmark Pharmaceuticals Inc USA | hydrocortisone valerate | 68462-836 |
| >Company | >Ingredient | >NDC |
hydrocortisone valerate drug variants not containing MINERAL OIL
Excipient focus: PETROLATUM
hydrocortisone valerate drug variants containing PETROLATUM
hydrocortisone valerate drug variants not containing PETROLATUM
| Company | Ingredient | NDC |
|---|---|---|
| Encube Ethicals Private Limited | hydrocortisone valerate cream | 21922-007 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYOXYL 20 CETOSTEARYL ETHER
hydrocortisone valerate drug variants containing POLYOXYL 20 CETOSTEARYL ETHER
| Company | Ingredient | NDC |
|---|---|---|
| Encube Ethicals Private Limited | hydrocortisone valerate cream | 21922-007 |
| >Company | >Ingredient | >NDC |
hydrocortisone valerate drug variants not containing POLYOXYL 20 CETOSTEARYL ETHER
Excipient focus: POLYSORBATE 80
hydrocortisone valerate drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Glenamrk Pharmaceuticals Inc USA | hydrocortisone valerate | 68462-575 |
| Glenmark Pharmaceuticals Inc USA | hydrocortisone valerate | 68462-836 |
| >Company | >Ingredient | >NDC |
hydrocortisone valerate drug variants not containing POLYSORBATE 80
Excipient focus: PROPYLENE GLYCOL
hydrocortisone valerate drug variants containing PROPYLENE GLYCOL
hydrocortisone valerate drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM ACRYLOYLDIMETHYLTAURATE
hydrocortisone valerate drug variants containing SODIUM ACRYLOYLDIMETHYLTAURATE
| Company | Ingredient | NDC |
|---|---|---|
| Glenamrk Pharmaceuticals Inc USA | hydrocortisone valerate | 68462-575 |
| Glenmark Pharmaceuticals Inc USA | hydrocortisone valerate | 68462-836 |
| >Company | >Ingredient | >NDC |
hydrocortisone valerate drug variants not containing SODIUM ACRYLOYLDIMETHYLTAURATE
Excipient focus: SODIUM LAURYL SULFATE
hydrocortisone valerate drug variants containing SODIUM LAURYL SULFATE
hydrocortisone valerate drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC
hydrocortisone valerate drug variants containing SODIUM PHOSPHATE, DIBASIC
hydrocortisone valerate drug variants not containing SODIUM PHOSPHATE, DIBASIC
Excipient focus: SODIUM PHOSPHATE, DIBASIC ANHYDROUS
hydrocortisone valerate drug variants containing SODIUM PHOSPHATE, DIBASIC ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | hydrocortisone valerate | 21695-730 |
| >Company | >Ingredient | >NDC |
hydrocortisone valerate drug variants not containing SODIUM PHOSPHATE, DIBASIC ANHYDROUS
Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
hydrocortisone valerate drug variants containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Cosette Pharmaceuticals Inc | hydrocortisone valerate | 0713-0560 |
| Cosette Pharmaceuticals Inc | hydrocortisone valerate | 0713-0720 |
| Taro Pharmaceuticals USA Inc | hydrocortisone valerate | 51672-1290 |
| Lupin Pharmaceuticals Inc | hydrocortisone valerate | 68180-954 |
| >Company | >Ingredient | >NDC |
hydrocortisone valerate drug variants not containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
Excipient focus: SORBIC ACID
hydrocortisone valerate drug variants containing SORBIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | hydrocortisone valerate | 45802-455 |
| A-S Medication Solutions | hydrocortisone valerate | 50090-2525 |
| DIRECT RX | hydrocortisone valerate | 61919-010 |
| >Company | >Ingredient | >NDC |
hydrocortisone valerate drug variants not containing SORBIC ACID
Excipient focus: STEARETH-100
hydrocortisone valerate drug variants containing STEARETH-100
hydrocortisone valerate drug variants not containing STEARETH-100
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | hydrocortisone valerate | 45802-455 |
| A-S Medication Solutions | hydrocortisone valerate | 50090-2525 |
| DIRECT RX | hydrocortisone valerate | 61919-010 |
| >Company | >Ingredient | >NDC |
Excipient focus: STEARETH-2
hydrocortisone valerate drug variants containing STEARETH-2
hydrocortisone valerate drug variants not containing STEARETH-2
Excipient focus: STEARYL ALCOHOL
hydrocortisone valerate drug variants containing STEARYL ALCOHOL
hydrocortisone valerate drug variants not containing STEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
hydrocortisone valerate drug variants containing WATER
hydrocortisone valerate drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WHITE PETROLATUM
hydrocortisone valerate drug variants containing WHITE PETROLATUM
| Company | Ingredient | NDC |
|---|---|---|
| Encube Ethicals Private Limited | hydrocortisone valerate cream | 21922-007 |
| >Company | >Ingredient | >NDC |
hydrocortisone valerate drug variants not containing WHITE PETROLATUM
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
